Greystone Associates
New survey examines potential for drug-coated devices
Published in FDA Law Weekly, November 18th, 2004
In currently approved products, these devices (e.g., coronary stents) provide a primary function, with the drug contributing therapeutic benefit that improves patient outcomes.
Ongoing improvements in specialty coating platforms are expanding the number of active compounds are can be formulated as drug-device combination products.
"We expect the clinical results from the current generation of coated device designs to yield valuable insight that...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of FDA Law Weekly
Source: FDA Law Weekly (2004-11-18)
More Articles from FDA Law Weekly
- AFSSA Alfort
West Nile virus has crossed geographical boundaries - Abbott Laboratories
FDA clears AxSYM immunoassay system - Advanced Brain Monitoring, Inc.
FDA clears ARES for in-home diagnosis of obstructive sleep apnea - Advanced Magnetics
U.S. FDA accepts response to approvable letter for Combidex - Affymetrix, Inc.
New microarray test funded by NIH - Agenix Limited
Blood-clot imaging technology gets U.S. FDA approval for phase 2 clinical trial - More from this issue of FDA Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
